Today: 19 April 2026
GE Vernova stock price slips as Power CEO exit keeps GEV in focus ahead of earnings
23 January 2026
2 mins read

GE Vernova stock price slips as Power CEO exit keeps GEV in focus ahead of earnings

NEW YORK, Jan 22, 2026, 18:23 (ET) — Trading in after-hours

  • Shares of GE Vernova slipped 0.93% to close at $661.67 and held steady in after-hours trading
  • An SEC filing revealed that Power segment CEO Mavi Zingoni has stepped down, with Eric Gray stepping in as the new head.
  • GE Vernova will release its fourth-quarter and full-year earnings on Jan. 28

Shares of GE Vernova Inc (GEV) dropped 0.9% on Thursday, continuing their slide following a regulatory filing revealing the head of its Power segment is stepping down. The stock ended the day at $661.67 and hovered near $662 in after-hours, after swinging between $645.26 and $679.33 during the session.

GE Vernova will release its fourth-quarter and full-year 2025 results on Jan. 28, ahead of the U.S. market open. CEO Scott Strazik and CFO Ken Parks will hold a webcast at 7:30 a.m. ET to go over the numbers, the company announced.

Power remains GE Vernova’s largest division, bringing in roughly $14 billion—about 51% of its revenue through the first nine months of 2025, according to Dow Jones Newswires. Gas Power drove over 80% of that segment’s revenue during the same stretch, the report added.

GE Vernova disclosed in an 8-K filing that Mavi Zingoni will step down as chief executive of the Power segment and as a company officer effective Jan. 21. She’ll remain on as an adviser through June 30. Eric Gray will assume the role of Power CEO while continuing to lead Gas Power, the filing revealed.

The filing didn’t specify the reason behind Zingoni’s departure. Shares were already sliding the day before, dropping 2.48% on Wednesday as the S&P 500 rose 1.16% and the Dow added 1.21%, according to MarketWatch data.

The executive shuffle comes as GE Vernova positions itself to supply data-center projects that demand reliable power. Strazik told Bloomberg that Big Tech could represent 25% of the company’s customers this year, up from 10% in 2025 and a “negligible” share in 2024, according to Energy Central. He added the surge has pushed the gas turbine backlog—orders taken but not yet fulfilled—to 80 gigawatts, while describing the wind order book as “much softer” amid a “complicated policy environment.” Energy Central

Investors tuning into the Jan. 28 call will be focused on updates about gas turbine orders, delivery slots, and pricing, especially as customers rush to secure equipment years in advance. Any remarks on cash generation usually hit this stock hard, too.

Just days ahead of results, the Power shake-up throws in another wildcard. If management signals caution on orders or margins—or if the wind weakness persists—the shares could quickly adjust downward.

After-hours trading often amplifies minor swings, so Friday’s regular session will reveal if buyers return. Technical traders are focused on whether the stock can maintain this week’s low around $645.

Traders outside the company are gearing up for new U.S. personal consumption expenditures inflation figures and the Federal Reserve’s upcoming decision next week, both of which could reshape rate forecasts and move industrial stocks. Investopedia highlighted PCE inflation as a crucial indicator for the Fed.

GE Vernova’s next big moment arrives Jan. 28, with results dropping before the bell followed by a webcast. Investors will be watching closely for clues on turbine demand from data centers and how the Power unit’s transition is shaping up—these details could shape sentiment heading into the next day’s trade.

Stock Market Today

  • Brown-Forman (BF.B) Faces Valuation Debate After Strong Short-Term Rally
    April 18, 2026, 9:26 PM EDT. Brown-Forman's (BF.B) stock surged about 27% in one month, reversing last year's roughly 11% decline. The recent sharp rebound contrasts with a weaker long-term trend, highlighting momentum shifts. Despite shares trading near analyst price targets at $29.15, fair value estimates diverge widely. Simply Wall St's discounted cash flow (DCF) model values Brown-Forman at $37.78, suggesting undervaluation, while another model pegs fair value at $21.00, indicating the stock is roughly 39% overvalued. The gap reflects differing views on declining global alcohol consumption due to rising health awareness, which could pressure Brown-Forman's revenue growth. However, premium spirits and emerging market demand might offset some risks. Investors face critical decisions amid mixed signals, weighing whether current prices embed growth prospects or overestimate future earnings.

Latest article

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

18 April 2026
Definium Therapeutics shares rose to $22.68 after Stifel and Piper Sandler initiated coverage with Buy ratings, citing late-stage trials of DT120, an LSD-based tablet for anxiety and depression. The company will host an investor day April 22 in New York to discuss upcoming Phase 3 data. DT120 is in four pivotal studies, with top-line results expected through 2026. Johnson & Johnson and Compass Pathways are advancing rival clinic-based psychiatric drugs.
Walmart stock slips after PhonePe IPO stake-sale plan; investors brace for CEO handover and earnings
Previous Story

Walmart stock slips after PhonePe IPO stake-sale plan; investors brace for CEO handover and earnings

Saudi Arabia gold price today slips after midweek jump as bullion tops $4,900
Next Story

Saudi Arabia gold price today slips after midweek jump as bullion tops $4,900

Go toTop